Top Tech Startups in Van Nuys in 2026

RDI is an overnight success — years in the making. We’re scaling fast (grew 4× last year), fueled by enterprise engagements with the top IVD manufacturers in the world. For a small team, we punch way above our weight. RDI has become the go-to CRO for large public diagnostics companies who rely on our creativity, tech-forward systems, and zero-excuses accountability to get trials done quickly and done right. We’re a fully integrated IVD CRO — a high-complexity CLIA lab, a technology-enabled CRO, and a national physician + lab network under one roof. This lets us run clinical trials with a level of speed and operational precision the industry isn’t used to. RDI was founded in 2008 and professionalized in 2017 through a search fund acquisition (not venture hype). We’re backed by long-term operators and growth investors — not dependent on VC burn or fundraising cycles. From 2022–2024, we expanded aggressively by doing the hard things right: building real infrastructure, earning trust from enterprise customers, and executing consistently. Our physician network was sourced from real insurance claims data and strengthened by CAP accreditation. No one has successfully started and scaled a modern CRO focused on diagnostics and medical devices in over 15 years. The industry is dominated by large, slow incumbents optimized for pharma — not speed, accountability, or precision. We’re the underdog — and we’re winning. Our goal is simple: prove our customers right, and prove the industry wrong. Get a feel for how we work: youtube.com/watch?v=3tccEbsWIl8